EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigallocatechin Gallate as a Potential Therapeutic Agent in Endometriosis: A Narrative Review

Anna Markowska iD, Zbigniew Kojs iD, Michał Antoszczak iD, Janina Markowska iD, Adam Huczyński iD

Nutrients · 21.06.2025 · 17 (13) · 2068

DOI: 10.3390/nu17132068 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.06.2025. Verfasst von Anna Markowska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Poznań University of Medical Sciences, Polna 33, 60-535 Poznań, Poland. Hauptthemen laut MEDLINE: Endometriosis, Catechin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is a chronic, hormone-dependent disease that affects women of reproductive age. It leads to numerous adverse clinical symptoms, which significantly impact women’s quality of life. The chronic nature of the disease and its recurrence are the main reasons for the search for new, non-hormonal drugs and drug candidates, either as adjunct treatment options or alternative therapies. The catechin found in green tea, epigallocatechin gallate (EGCG), has been shown to exhibit a wide array of biological activities, which may also contribute to its potential effectiveness in treating endometriosis. The poor physicochemical stability and relatively low bioavailability of EGCG have stimulated the development of a peracetylated prodrug (pro-EGCG) and other solutions, based on nanotechnology, that would eliminate the problems with EGCG. In this review article, we summarize the studies on the effects of EGCG, pro-EGCG, and EGCG-based nanoparticles on the course of endometriosis published in the GoogleScholar and PubMed databases. Of note is the fact that the results of in vitro and animal model studies have suggested that EGCG and pro-EGCG can reduce the number of endometriosis foci and their size and volume, and they can prevent fibrosis by affecting multiple molecular factors and signaling pathways. The promising results provide a basis for using green herbal extracts for endometriosis treatment in a clinical trial. Nevertheless, it should be emphasized that the number of studies on the topic is currently very limited; further expansion in the coming years is necessary. Broad, well-designed clinical trials are also essential to validate the true potential of EGCG and related compounds in the fight against endometriosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisCatechinHumansFemaleAnimalsNanoparticles

Stichwörter der Autor:innen

EGCG octaacetateclinical trialsendometriosisepigallocatechin-3-gallategreen teain vitroin vivonanoparticlesprodrugs

Substanzen

epigallocatechin gallateCatechin

Autor:innen und Institutionen

  • Department of Perinatology, Poznań University of Medical Sciences, Polna 33, 60-535 Poznań, Poland.
  • Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, Złotej Jesieni 1, 31-626 Kraków, Poland.
  • Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland.
  • Gynecological Oncology Center, Poznańska 58A, 60-850 Poznań, Poland.

ORCID-Profile: Anna Markowska, Zbigniew Kojs, Michał Antoszczak, Janina Markowska, Adam Huczyński

Zitieren

APA

Markowska, A., Kojs, Z., Antoszczak, M., Markowska, J., & Huczyński, A. (2025). Epigallocatechin Gallate as a Potential Therapeutic Agent in Endometriosis: A Narrative Review. Nutrients, 17(13), 2068. https://doi.org/10.3390/nu17132068

Vancouver

Markowska A, Kojs Z, Antoszczak M, Markowska J, Huczyński A. Epigallocatechin Gallate as a Potential Therapeutic Agent in Endometriosis: A Narrative Review. Nutrients. 2025;17(13):2068. doi:10.3390/nu17132068

BibTeX
@article{Markowska2025,
  author = {Markowska, Anna and Kojs, Zbigniew and Antoszczak, Michał and Markowska, Janina and Huczyński, Adam},
  title = {Epigallocatechin Gallate as a Potential Therapeutic Agent in Endometriosis: A Narrative Review},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2068},
  doi = {10.3390/nu17132068}
}
Kostenlos starten →